ImmuneOncia Therapeutics424870

Largest holderYuhan55.89%$92M

Filed holders45% or more, plus insiders

Price and institutional trades

1Y 2Y

$1.78−54.9%1Y

DecJanFebMarAprMayJunJulAugSepOctNov

Holders

$92M · 2026-05-2755.89%

3 other related parties$2.2M1.35%

Average cost is the mean purchase price from filings since November 2024. Indirect stakes multiply ownership through listed companies.

Indirect-only holders

$7.3M · indirect4.44%

Yuhan 7.94% → ImmuneOncia Therapeutics 55.89%4.44%

$6.0M · indirect3.63%

Yuhan 0.89% → ImmuneOncia Therapeutics 55.89%0.50%
Yuhan 0.05% → ImmuneOncia Therapeutics 55.89%0.03%
Yuhan 0.02% → ImmuneOncia Therapeutics 55.89%0.01%
Yuhan 0.03% → ImmuneOncia Therapeutics 55.89%0.02%
Yuhan 0.88% → ImmuneOncia Therapeutics 55.89%0.49%
Yuhan 0.02% → ImmuneOncia Therapeutics 55.89%0.01%
Yuhan 0.29% → ImmuneOncia Therapeutics 55.89%0.16%
Yuhan 0.03% → ImmuneOncia Therapeutics 55.89%0.02%
Yuhan 0.03% → ImmuneOncia Therapeutics 55.89%0.02%
0.02% → ImmuneOncia Therapeutics 55.89%

Filings

Filed	Changed	Before → after	Amount	Avg buy price
2026-05-27	2026-05-22	67.37 → 57.23%	+$9.9M	$3.60	Filing
2026-04-30	2026-04-23	67.58 → 67.37%	+$12M	$0.37	Filing
2026-04-22	-	66.97 → 70.18%	+$60M	-	Filing
2025-05-23	2025-05-19	67.58%	-	-	Filing

4 in the last 2 years · amount = quantity × price per trade in the last year (closing price where no price is filed), avg buy price = average of buys in that filing · change dates and prices only where the original filing was fetched